While rare, some people taking semaglutide and tirzepatide have reported hair loss
DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
When your liver breaks down acetaminophen, a small portion converts into NAPQI, a toxic byproduct that normally gets neutralized by glutathione
Homeostatic adaptation : The bodys internal regulatory mechanisms (e.g., blood pressure, heart rate, temperature) adjust to the presence of the substance, and without it, these systems overshoot or fluctuate, causing physiological symptoms
doi: 10.1016/j.biopha.2022.114171
